Ninlaro
| Ninlaro | |
|---|---|
| Term | Ninlaro |
| Short definition | nimotuzumab - (pronounced) (ny-moh-TOO-zoo-mab) substance being studied to treat some types of cancer. Nimotuzumab attaches to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Ninlaro - (pronounced) (nin-LAR-oh) drug used with lenalidomide and dexamethasone to treat multiple myeloma. It is used in patients who have received at least one other cancer treatment. It is also being studied in the treatment of other types of cancer. Ninlaro blocks the action of enzymes called proteasomes, which can help stop cancer cells from growing and kill them. It's a type of proteasome inhibitor. Also called ixazomib citrate
External links
- Medical encyclopedia article on Ninlaro
- Wikipedia's article - Ninlaro
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski